EFTA00449178Set 9
2017-04-083p1,317w
genetic backgrounds and mutations may have on AD pathologies in
vivo.
Espuny-Camacho I, Arranz AM, Fiers M, Snellinx A, Ando K, Munck S, Bonnefont J, Lambot L, Corthout
https://www.justice.gov/epstein/files/DataSet%209/EFTA00449178.pdf
EFTA00449175Set 9
2017-04-083p1,321w
genetic backgrounds and mutations may have on AD pathologies in vivo.
Espuny-Camacho I, Arranz AM, Fiers M, Snellinx A, Ando K, Munck S, Bonnefont J, Lambot L, Corthout
https://www.justice.gov/epstein/files/DataSet%209/EFTA00449175.pdf
EFTA00449354Set 9
2017-04-104p1,361w
genetic backgrounds and mutations may have on AD pathologies in
vivo.
Espuny-Camacho I, Arranz AM, Fiers M, Snellinx A, Ando K, Munck S, Bonnefont J, Lambot L, Corthout
https://www.justice.gov/epstein/files/DataSet%209/EFTA00449354.pdf
EFTA00686132Set 9
2017-04-083p1,187w
genetic backgrounds and mutations may have on AD pathologies in vivo.
Espuny-Camacho I, Arranz AM, Fiers M, Snellinx A, Ando K, Munck 5, Bonnefont 1, Lambot L, Corthout
https://www.justice.gov/epstein/files/DataSet%209/EFTA00686132.pdf